FAST NEWS: InnoCare Pharma Slumps after Flagship Drug Included on China’s National List
The latest: InnoCare Pharma Ltd. (9969.HK) said late Friday that its Bruton’s tyrosine kinase inhibitor Orelabrutinib, used to treat lymphoma and autoimmune diseases, has been included on the National Reimbursement…
